Allan Kristensen

1.0k total citations
16 papers, 712 citations indexed

About

Allan Kristensen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Allan Kristensen has authored 16 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Allan Kristensen's work include Muscle Physiology and Disorders (5 papers), Cardiomyopathy and Myosin Studies (3 papers) and HIV-related health complications and treatments (3 papers). Allan Kristensen is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Cardiomyopathy and Myosin Studies (3 papers) and HIV-related health complications and treatments (3 papers). Allan Kristensen collaborates with scholars based in United States, Sweden and France. Allan Kristensen's co-authors include Svein Skeie, Eberhard Draeger, Jean-Louis Sélam, P Vague, Hanne Haahr, Jan Willem F. Elte, I. De Leeuw, Sten Madsbad, Mads Axelsen and Kjeld Hermansen and has published in prestigious journals such as Blood, Neurology and Diabetes Care.

In The Last Decade

Allan Kristensen

16 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan Kristensen United States 8 434 283 261 164 99 16 712
G A Werther Australia 12 488 1.1× 249 0.9× 159 0.6× 124 0.8× 26 0.3× 20 656
Andreas Moraitis United States 14 309 0.7× 56 0.2× 228 0.9× 143 0.9× 9 0.1× 41 565
Doris Taha United States 13 266 0.6× 378 1.3× 331 1.3× 238 1.5× 36 0.4× 27 655
Jürgen Herwig Germany 9 192 0.4× 379 1.3× 100 0.4× 157 1.0× 13 0.1× 12 705
Francesca Dassie Italy 16 351 0.8× 77 0.3× 145 0.6× 68 0.4× 11 0.1× 51 531
Patrick Lim Australia 8 141 0.3× 128 0.5× 37 0.1× 195 1.2× 109 1.1× 13 485
Shuo Lin China 12 181 0.4× 48 0.2× 111 0.4× 139 0.8× 25 0.3× 38 435
Beatriz Lecumberri Spain 13 188 0.4× 201 0.7× 145 0.6× 214 1.3× 19 0.2× 32 600
A. Gessi Italy 6 252 0.6× 112 0.4× 225 0.9× 199 1.2× 43 0.4× 7 542
Sameer Kassem Israel 8 291 0.7× 227 0.8× 321 1.2× 156 1.0× 10 0.1× 33 560

Countries citing papers authored by Allan Kristensen

Since Specialization
Citations

This map shows the geographic impact of Allan Kristensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Kristensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Kristensen more than expected).

Fields of papers citing papers by Allan Kristensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Kristensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Kristensen. The network helps show where Allan Kristensen may publish in the future.

Co-authorship network of co-authors of Allan Kristensen

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Kristensen. A scholar is included among the top collaborators of Allan Kristensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Kristensen. Allan Kristensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gao, Lan, Anuradha Bhattacharyya, Diksha Kaushik, et al.. (2024). Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first‐in‐human study. British Journal of Clinical Pharmacology. 90(12). 3242–3251. 4 indexed citations
2.
Laskin, Oscar L., Diksha Kaushik, Jiyuan Ma, et al.. (2023). A pharmacokinetic drug–drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV‐2 (COVID‐19) DHODH (dihydroorotate dehydrogenase) inhibitor. Pharmacology Research & Perspectives. 11(2). e01076–e01076. 2 indexed citations
3.
Mercuri, Eugenio, A. Nascimento Osorio, Francesco Muntoni, et al.. (2023). Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis. Journal of Neurology. 270(8). 3896–3913. 21 indexed citations
4.
Laskin, Oscar L., Diksha Kaushik, Jiyuan Ma, et al.. (2023). A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor. European Journal of Clinical Pharmacology. 79(8). 1073–1080. 2 indexed citations
5.
Stephens, Carolyn, et al.. (2022). Aromatic L-amino acid decarboxylase deficiency: a systematic review. Future Neurology. 17(4). 7 indexed citations
6.
McDonald, Craig M., Francesco Muntoni, Mark Rance, et al.. (2021). Ataluren Delays Loss of Ambulation and Decline in Pulmonary Function in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (2553). Neurology. 96(15_supplement). 1 indexed citations
7.
Mercuri, Eugenio, Francesco Muntoni, A. Nascimento Osorio, et al.. (2020). Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study. Journal of Comparative Effectiveness Research. 9(5). 341–360. 73 indexed citations
8.
Desguerre, Isabelle, Francesco Muntoni, A. Nascimento Osorio, et al.. (2019). Effect of Ataluren on Age at Loss of Ambulation in Nonsense Mutation Duchenne Muscular Dystrophy: Observational Data from the STRIDE Registry (P1.6-067). Neurology. 92(15_supplement). 1 indexed citations
9.
Christopher, Ronald, Jim Ferry, Bhaskar Rege, et al.. (2016). Single- and Multiple-dose Pharmacokinetics of a Lorcaserin Extended-release Tablet. Clinical Therapeutics. 38(10). 2227–2238.e4. 10 indexed citations
10.
Lesimple, Thierry, Julien Edeline, Timothy J. Carrothers, et al.. (2012). A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors. Investigational New Drugs. 31(4). 900–909. 16 indexed citations
11.
Wanke, Christine, et al.. (2007). Safety and Efficacy of Two Preparations of Megestrol Acetate in HIV-Infected Individuals with Weight Loss in Africa, India, and the United States. 5 indexed citations
12.
13.
14.
McSorley, P., P. M. Bell, Lisbeth V. Jacobsen, Allan Kristensen, & Anders Lindholm. (2002). Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: A double-blind crossover study in adults with type 2 diabetes mellitus. Clinical Therapeutics. 24(4). 530–539. 72 indexed citations
15.
Ewertz, Marianne, Lars Holmberg, Steinar Tretli, Bo V. Pedersen, & Allan Kristensen. (2001). Risk Factors for Male Breast Cancer—A Case-Control Study from Scandinavia. Acta Oncologica. 40(4). 467–471. 127 indexed citations
16.
Hermansen, Kjeld, Sten Madsbad, Hans Perrild, Allan Kristensen, & Mads Axelsen. (2001). Comparison of the Soluble Basal Insulin Analog Insulin Detemir With NPH Insulin. Diabetes Care. 24(2). 296–301. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G A Werther Breakdown of academic impact, for papers by Andreas Moraitis Breakdown of academic impact, for papers by Doris Taha Breakdown of academic impact, for papers by Jürgen Herwig Breakdown of academic impact, for papers by Francesca Dassie Breakdown of academic impact, for papers by Patrick Lim Breakdown of academic impact, for papers by Shuo Lin Breakdown of academic impact, for papers by Beatriz Lecumberri Breakdown of academic impact, for papers by A. Gessi Breakdown of academic impact, for papers by Sameer Kassem
Rankless by CCL
2026